Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$356.95 - $413.29 $2,855 - $3,306
8 Added 0.15%
5,206 $2.05 Million
Q4 2023

Feb 13, 2024

BUY
$338.91 - $506.01 $986,567 - $1.47 Million
2,911 Added 127.28%
5,198 $1.98 Million
Q3 2023

Nov 13, 2023

BUY
$369.35 - $548.43 $844,703 - $1.25 Million
2,287 New
2,287 $1.12 Million
Q4 2022

Feb 10, 2023

SELL
$342.17 - $402.31 $160,819 - $189,085
-470 Reduced 16.68%
2,348 $889,000
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $967,137 - $1.12 Million
2,818 New
2,818 $995,000
Q2 2022

Aug 10, 2022

SELL
$269.58 - $378.88 $3.44 Million - $4.84 Million
-12,770 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$254.45 - $351.06 $2.42 Million - $3.34 Million
-9,514 Reduced 42.69%
12,770 $4.03 Million
Q4 2021

Feb 14, 2022

BUY
$272.01 - $353.03 $2.87 Million - $3.72 Million
10,546 Added 89.84%
22,284 $7.8 Million
Q3 2021

Nov 15, 2021

BUY
$295.0 - $350.58 $339,250 - $403,167
1,150 Added 10.86%
11,738 $3.55 Million
Q2 2021

Aug 16, 2021

BUY
$257.11 - $319.92 $555,357 - $691,027
2,160 Added 25.63%
10,588 $3.19 Million
Q1 2021

May 20, 2021

SELL
$268.3 - $380.31 $21.6 Million - $30.6 Million
-80,505 Reduced 90.52%
8,428 $2.32 Million
Q1 2021

May 14, 2021

BUY
$268.3 - $380.31 $23.9 Million - $33.8 Million
88,933 New
88,933 $24.5 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Optiver Holding B.V. Portfolio

Follow Optiver Holding B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.